US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
ヨーロッパ
EU
THX Pharma (ALTHX) 銘柄情報

THX Pharma (ALTHX)

3.19

0.015

(0.47%)

終了 6月14日 12:30AM

THX Pharma (ALTHX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

3.19

( 0.47% )

買値

3.15

売値

3.215

出来高

19,882

3.135 日の範囲 3.24

0.742 52 週間の範囲 5.10

時価総額

前日終値

3.175

始値

3.24

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

98,580 €

発行済株式数

13,796,556

配当利回り

PER

-14.48

1 株当たり利益 (EPS)

-0.22

歳入

806.05k

純利益

-3M

THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The compan... THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.theranexus.com

本社

Lyon, France

設立

2026

THX Pharma is listed in the Healthcare sector of the ユーロネクスト with ticker ALTHX. The last closing price for THX Pharma was 3.18 €. Over the last year, THX Pharma shares have traded in a share price range of 0.742 € to 5.10 €.

THX Pharma currently has 13,796,556 shares in issue. The market capitalisation of THX Pharma is 44.01 € million. THX Pharma has a price to earnings ratio (PE ratio) of -14.48.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.09	2.90322580645	3.1	3.37	3.055	66004	3.16565105	DE
4	-0.32	-9.11680911681	3.51	4.05	3.04	105515	3.47629278	DE
12	0.14	4.59016393443	3.05	4.05	2.8	103926	3.38870545	DE
26	0.98	44.3438914027	2.21	5.1	1.83	152066	3.22868262	DE
52	2.254	240.811965812	0.936	5.1	0.742	152431	2.81920927	DE
156	1.1	52.6315789474	2.09	5.1	0.2605	70257	2.06164423	DE
260	-9.29	-74.4391025641	12.48	13.78	0.2605	52774	2.66642564	DE

ALTHX - Frequently Asked Questions (FAQ)

What is the current THX Pharma share price?

The current share price of THX Pharma is 3.19 €

How many THX Pharma shares are in issue?

THX Pharma has 13,796,556 shares in issue

What is the market cap of THX Pharma?

The market capitalisation of THX Pharma is EUR 44.01M

What is the 1 year trading range for THX Pharma share price?

THX Pharma has traded in the range of 0.742 € to 5.10 € during the past year

What is the PE ratio of THX Pharma?

The price to earnings ratio of THX Pharma is -14.48

What is the cash to sales ratio of THX Pharma?

The cash to sales ratio of THX Pharma is 53.92

What is the registered address of THX Pharma?

The registered address for THX Pharma is 60, Avenue Rockefeller, Lyon, Rhône-Alpes, 69008

What is the THX Pharma website address?

The website address for THX Pharma is www.theranexus.com

Which industry sector does THX Pharma operate in?

THX Pharma operates in the Biotechnology & Life Sciences sector

TrendTrade2016

TrendTrade2016 6分前

IHUBS fake traders and fake short traders like Monkfishmaggot and the other fake Orion traders have been losing their minds, calling 20 tickers a day and never losing…lol. The OTC clowns and junkies have been smoking more crack into their depression, Fakechartmaster and king of the maggots, great

$PennyMover

$PennyMover 7分前

Seems they may have folded. Every link is 404 or invalid. SEC must be involved now...smh

x993231

x993231 11分前

SPCX will reuse rockets over and over. Musk said not to do so would be like getting a new airplane everytime you fly.

X

Big P1

Big P1 13分前

SOMEONE EMAIL THIS CLOWN AND ASK HIM WHAT IS GOING ON

jstein@jmslg.com

He won't reply to me

chuck1418

chuck1418 14分前

peptides are the going thing right now. good time to be evolved. potential here.

jay_tee

jay_tee 16分前

jay_tee

jay_tee 18分前

Good thing AI currently isn’t the say all do all source! Here’s its response to “Will Seamus Lagan get RNVA current?” SMH
No, Seamus Lagan is not working to get Rennova Health (RNVA) "OTC Pink Current."
Instead, his strategy has completely shifted toward a different public company.The

Investor082

Investor082 19分前

Just like that lie LG uttered on Big Booz show 6 years ago that UK approval is imminent. Of course, he never said that, LOL! ;)

Just the facts maam

Just the facts maam 20分前

Just checked the FDA Complete Response Database, no indication that ANIP received a CRL for their outstanding Q3 2023 NDA (most likely Libigel). It should still be in play.

ellegi

ellegi 28分前

I own a million shares. and a friend of mine too. 👍️

StarlingChaser

StarlingChaser 28分前

Leaving to go camping this evening myself but wasn’t me either.

ohsaycanyousee82

ohsaycanyousee82 33分前

You even downplayed the significance of her sale of shares here.

But hey! Who’s really counting anyway?

Hosai

No long term shareholder wants a buyout with sp down here, why would the company be seeking one? If the bears were correct and it was all a fraud etc then it wouldn't be bought out anyway so it seems unlikely in both bullish and bearish narratives.
They would obv like a partnership for the ph

NASDAQ2020

NASDAQ2020 43分前

Difference Between Paragraph 3 and Paragraph 4 Filing in an ANDA
In an Abbreviated New Drug Application (ANDA), the USFDA requires generic applicants to certify how their product relates to patents listed in the Orange Book for the reference-listed drug (RLD). This certification is categorize

ohsaycanyousee82

ohsaycanyousee82 43分前

“About the same time that I sold the lion share of my holdings.”

If you classify 7% of your core as “the lions” share. Or maybe that was the lyin’s share. But the again, there was always fog surrounding “core” and “trading” shares.

Yes, the posts don’t simply fade awa

JamesF1

JamesF1 44分前

The company does not need a buyout. The right offer would be accepted, but it’s not a fire sale.

TrendTrade2016

TrendTrade2016 45分前

What happened to the cashmere sweater pump….or will they be using copper thread to create conductivity, so the sweater’s can be used as portable data storage and turn the sweater into an Artificial device. Fusion reactors, alternative jet fuel and now copper cashmere bags to add to the illusions. Do

iHub News

iHub News 45分前

Standard Chartered Says Crypto Market Has Likely Found Its BottomJune 14, 2026 6:52 AM
IH Market News

iHub News

iHub News 45分前

Standard Chartered Says Crypto Market Has Likely Found Its BottomJune 14, 2026 6:52 AM
IH Market News

Wayne R

Wayne R 1時間前

The physics aren't physicing, the math isn't mathing and without free money from US citizens, the company wouldn't be companying

JMO

EZ2

11-12-22-24. 🙏

FlashySage44

FlashySage44 2時間前

The day of reckoning is coming.
Two and a half weeks until the Next ER.
8 and a half until the August one.
No buyout in sight.
When will the longs start to question the buyout not happening?
I am very interested to see what this place will be saying come September

2.75% 2028 Bond 2.75% 2028

Franklin AI Metaverse an...

Terravest Industries (PK)

Bank Polska Kasa Opieki (PK)

BNP Paribas Easy JPM Til...

Dummy Utp Historical Data

Kirby Corp Dl 0 10

Americas Car Mart

OMX Stockholm Media PI

Investec Bnk 23

Be Semiconductor Industr...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。